Ignite Creation Date:
2025-12-26 @ 11:09 AM
Ignite Modification Date:
2025-12-31 @ 8:23 PM
Study NCT ID:
NCT05241912
Status:
UNKNOWN
Last Update Posted:
2022-02-16
First Post:
2022-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Supernormal Oxygen Delivery for Patients With Severe Burns
Sponsor:
Guangzhou Red Cross Hospital
Organization:
Study Overview
Official Title:
Supernormal Oxygen Delivery for Patients With Severe Burns：A Randomized Controlled Trial
Status:
UNKNOWN
Status Verified Date:
2022-01
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized double-blinded study to investigate in which the groups are designated as the control group and the goal-directed fluid therapy group to further evaluate significant differences in rate of complications during burn surgery.
Detailed Description:
This is a randomized double-blinded study to investigate the effect of control group and the goal-directed fluid therapy group on complications during surgery of the burn patients. The groups are designated as the control group and the oal-directed fluid therapy group to further evaluate significant differences in complications during the surgery.
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: